Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ANGONASDAQ:ATECNASDAQ:OFIXNASDAQ:SRDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeANGOAngioDynamics$10.02-2.1%$9.81$5.47▼$13.50$406.88M0.62581,120 shs777,455 shsATECAlphatec$10.94+0.5%$11.80$4.88▼$13.14$1.60B1.12.06 million shs2.08 million shsOFIXORTHOFIX MEDICAL$10.34-0.1%$12.08$10.25▼$20.73$404.94M0.8281,301 shs814,462 shsSRDXSurmodics$29.00-0.5%$28.73$26.00▼$42.44$414.67M1.33243,465 shs177,222 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceANGOAngioDynamics0.00%-6.00%+6.48%+1.01%+77.35%ATECAlphatec0.00%-1.08%-12.34%+10.17%+5.39%OFIXORTHOFIX MEDICAL0.00%-6.00%-7.93%-37.82%-19.66%SRDXSurmodics0.00%-0.55%-0.55%-4.54%-30.85%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationANGOAngioDynamics4.1334 of 5 stars3.52.00.04.23.21.70.6ATECAlphatec4.4698 of 5 stars3.43.00.03.33.24.20.6OFIXORTHOFIX MEDICAL2.8249 of 5 stars3.42.00.00.01.43.31.3SRDXSurmodics3.377 of 5 stars3.33.00.03.40.01.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceANGOAngioDynamics 3.00Buy$14.0039.72% UpsideATECAlphatec 2.89Moderate Buy$17.8963.52% UpsideOFIXORTHOFIX MEDICAL 2.75Moderate Buy$23.33125.66% UpsideSRDXSurmodics 2.50Moderate Buy$43.0048.28% UpsideCurrent Analyst Ratings BreakdownLatest ANGO, ATEC, OFIX, and SRDX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025ATECAlphatecLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy$18.006/6/2025OFIXORTHOFIX MEDICALJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform5/2/2025ATECAlphatecPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$13.00 ➝ $15.005/2/2025ATECAlphatecNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.004/30/2025SRDXSurmodicsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold4/14/2025ATECAlphatecHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$20.00 ➝ $20.004/7/2025ANGOAngioDynamicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $16.00(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookANGOAngioDynamics$303.91M1.34$4.28 per share2.34$5.13 per share1.95ATECAlphatec$611.56M2.61N/AN/A($0.10) per share-109.40OFIXORTHOFIX MEDICAL$799.49M0.51N/AN/A$13.07 per share0.79SRDXSurmodics$126.08M3.29$0.31 per share93.73$8.33 per share3.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateANGOAngioDynamics-$184.35M-$1.01N/AN/AN/A-14.61%-3.73%-2.43%7/15/2025 (Estimated)ATECAlphatec-$162.12M-$1.15N/AN/AN/A-25.77%-1,657.19%-21.53%7/30/2025 (Estimated)OFIXORTHOFIX MEDICAL-$126M-$3.69N/AN/AN/A-17.78%-28.15%-16.51%8/5/2025 (Estimated)SRDXSurmodics-$11.54M-$1.39N/A36.25N/A-16.34%-7.10%-4.77%7/30/2025 (Estimated)Latest ANGO, ATEC, OFIX, and SRDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/15/2025Q4 2025ANGOAngioDynamics-$0.13N/AN/AN/A$74.26 millionN/A5/1/2025Q1 2025ATECAlphatec-$0.12-$0.35-$0.23-$0.35$167.57 million$169.18 million4/30/2025Q2 2025SRDXSurmodics-$0.06-$0.13-$0.07-$0.36$32.23 million$28.09 million4/2/2025Q3 2025ANGOAngioDynamics-$0.13$0.03+$0.16-$0.11$70.30 million$72.00 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthANGOAngioDynamicsN/AN/AN/AN/AN/AATECAlphatecN/AN/AN/AN/AN/AOFIXORTHOFIX MEDICALN/AN/AN/AN/AN/ASRDXSurmodicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioANGOAngioDynamicsN/A2.211.40ATECAlphatecN/A2.751.67OFIXORTHOFIX MEDICAL0.382.711.50SRDXSurmodics0.275.143.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipANGOAngioDynamics89.43%ATECAlphatec66.35%OFIXORTHOFIX MEDICAL89.76%SRDXSurmodics96.63%Insider OwnershipCompanyInsider OwnershipANGOAngioDynamics5.40%ATECAlphatec20.90%OFIXORTHOFIX MEDICAL1.30%SRDXSurmodics8.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableANGOAngioDynamics76040.61 million38.41 millionOptionableATECAlphatec700146.17 million115.62 millionOptionableOFIXORTHOFIX MEDICAL1,61639.18 million38.67 millionOptionableSRDXSurmodics45014.30 million13.03 millionOptionableANGO, ATEC, OFIX, and SRDX HeadlinesRecent News About These CompaniesCalifornia State Teachers Retirement System Boosts Stake in Surmodics, Inc. (NASDAQ:SRDX)June 8, 2025 | marketbeat.comQuidelOrtho (QDEL) Down 18% Since Last Earnings Report: Can It Rebound?June 6, 2025 | msn.comZacks Research Has Negative Outlook of Surmodics Q3 EarningsMay 31, 2025 | marketbeat.comWhy Is SurModics (SRDX) Up 6% Since Last Earnings Report?May 30, 2025 | zacks.comWhat is Zacks Research's Forecast for Surmodics Q2 Earnings?May 30, 2025 | marketbeat.comPhocas Financial Corp. Purchases 15,534 Shares of Surmodics, Inc. (NASDAQ:SRDX)May 28, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Purchased by Squarepoint Ops LLCMay 27, 2025 | marketbeat.comEquities Analysts Set Expectations for Surmodics Q3 EarningsMay 27, 2025 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Bought by Deutsche Bank AGMay 26, 2025 | marketbeat.comAlpine Global Management LLC Takes $1.98 Million Position in Surmodics, Inc. (NASDAQ:SRDX)May 25, 2025 | marketbeat.comSurmodics, Ballinasloe, offers production operator opportunitiesMay 16, 2025 | advertiser.ieAre Options Traders Betting on a Big Move in Surmodics Stock?May 2, 2025 | msn.comSRDX Stock Down Following Q2 Earnings Miss, Gross Margin ContractsMay 1, 2025 | zacks.comSurmodics stock takes another hit on Q2 miss and 2025 guidanceApril 30, 2025 | massdevice.comSurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to SayApril 30, 2025 | zacks.comSurModics (SRDX) Reports Q2 Loss, Misses Revenue EstimatesApril 30, 2025 | zacks.comSurmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial GuidanceApril 30, 2025 | businesswire.comA Look at Surmodics's Upcoming Earnings ReportApril 30, 2025 | benzinga.comSurmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30April 28, 2025 | businesswire.comResults Published From TRANSCEND Study of Surmodics SurVeil DCBApril 23, 2025 | evtoday.comSurmodics publishes TRANSCEND trial dataApril 22, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeANGO, ATEC, OFIX, and SRDX Company DescriptionsAngioDynamics NASDAQ:ANGO$10.02 -0.21 (-2.05%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$10.02 0.00 (0.00%) As of 06/20/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.Alphatec NASDAQ:ATEC$10.94 +0.05 (+0.46%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$10.94 +0.01 (+0.05%) As of 06/20/2025 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.ORTHOFIX MEDICAL NASDAQ:OFIX$10.34 -0.01 (-0.10%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$10.34 0.00 (-0.05%) As of 06/20/2025 04:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.Surmodics NASDAQ:SRDX$29.00 -0.14 (-0.48%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$29.01 +0.01 (+0.03%) As of 06/20/2025 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
